| Drug General Information |
| Drug ID |
D0R1VU
|
| Former ID |
DCL000194
|
| Drug Name |
Perifosine
|
| Synonyms |
D 21266; NKA17; D-21266; KRX-0401; KRX-0401, NSC 639966; Octadecyl-(1,1-dimethyl-4-piperidylio)phosphate; Piperidinium, 4-[[hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethyl-, inner salt; Piperidinium, 4-((hydroxy(octadecyloxy)phosphinyl)oxy)-1,1-dimethyl-, inner salt; (1,1-dimethylpiperidin-1-ium-4-yl) octadecyl phosphate; 4-((Hydroxy(octadecyloxy)phosphinyl)oxy)-1,1-dimethylpiperidinium inner salt
|
| Drug Type |
Small molecular drug
|
| Therapeutic Class |
Anticancer Agents
|
| Company |
AEterna Zentaris
|
| Structure |
|
Download
2D MOL
3D MOL
|
| Formula |
C25H52NO4P
|
| InChI |
InChI=1S/C25H52NO4P/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-24-29-31(27,28)30-25-20-22-26(2,3)23-21-25/h25H,4-24H2,1-3H3
|
| InChIKey |
SZFPYBIJACMNJV-UHFFFAOYSA-N
|
| PubChem Compound ID |
|
| PubChem Substance ID |
499931, 10249827, 12014848, 14760465, 46225126, 50522741, 53788324, 57346714, 85246193, 93310442, 99437196, 103470071, 103910923, 104418415, 109693544, 118049497, 118844937, 123051101, 124756952, 124898782, 125163758, 125342051, 126635176, 126666969, 126730749, 127342249, 127342250, 134338862, 135105241, 135727424, 136380272, 137241823, 138570989, 139786486, 143493383, 144206916, 152211795, 152234886, 152258856, 152344202, 160645447, 160821709, 162011855, 162190947, 163091653, 163686461, 164041887, 164160505, 164232283, 164825248
|
| Target and Pathway |
| References |
